Maxim Sotrihin

Title: Maxim Sotrihin: Innovator in Pharmaceutical Processes

Introduction: Maxim Sotrihin, an accomplished inventor based in Haifa, Israel, has made significant contributions to the field of pharmaceuticals. With a total of two patents to his name, Sotrihin's work focuses on innovative processes for the preparation of vital pharmaceutical compounds.

Latest Patents: Among his latest patents is the "Process for the Preparation of Dexmethylphenidate Hydrochloride." This invention presents an efficient method for synthesizing dexmethylphenidate hydrochloride with high optical purity. The process introduces a new intermediate: salt of (R,R)-N-Boc-ritalinic acid with (S)-1-phenylethylamine, enhancing the preparation of this crucial compound. His second patent, titled "Process for the Preparation of Threo-Methylphenidate Hydrochloride," offers a detailed methodology to produce threo-methylphenidate hydrochloride through a series of well-defined steps, showing his commitment to advancing pharmaceutical manufacturing.

Career Highlights: Maxim Sotrihin is currently associated with Isp Investments Inc., where he continues to refine and develop innovative pharmaceutical processes. His dedication to research and development has paved the way for new medications and treatments, showcasing his expertise and commitment to the field.

Collaborations: Throughout his career, Sotrihin has collaborated with several notable professionals, including Arie L Gutman and Igor Zaltsman. These collaborations have further enriched his innovative capacity and expanded the scope of his research endeavors.

Conclusion: Maxim Sotrihin stands out as a remarkable inventor specializing in pharmaceutical processes. With his innovative patents, he contributes significantly to advancements in the industry, demonstrating the impact of inventive thinking on healthcare and medicine. His work not only aids in drug preparation but also embodies the essence of modern pharmaceutical innovation.